Side by side
Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Trade union · France
Other · Germany
Declared costs: €200K+ a year · in the register since 2009
Compulsory licensing of patents in crisis situations · Supplementary protection certificate for plant protection products. Recast
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
Leem · filed 29 Apr 2022 · source
The substantial investment in R&D by multiple actors over many years into novel technologies, vaccine, therapeutic and other products now available to address Covid-19 would not have occurred without the robust IP system in the EU and elsewhere. IP, particularly patents, has provided the legal framework and incentive for the high risk, high-cost investment underpinning the response to the pandemic.
Deutscher Anwaltverein e.V. · filed 29 Apr 2022 · source
Please find enclosed the opinion of the German Lawyers’ Association (DAV) by the Intellectual Property Committee on the Commission’s impact assessment on compulsory licensing in the EU. The DAV welcomed in principle an evaluation of the compulsory licensing system for patents. However, the DAV is critical of the creation of a uniform system of compulsory licensing in the EU.
Filed in German · English published by the European Commission
Deutscher Anwaltverein e.V. · filed 4 Apr 2022 · source
The Deutscher Anwaltverein (DAV) is the professional association for lawyers in Germany; membership is optional. The DAV brings together more than 61 000 lawyers and notaries of lawyers, organised in 252 local lawyers’ clubs at home and abroad. He represents the interests of the German Bar at national, European and international level. This opinion responds to the Commission’s request of 8.3.2022.
Filed in German · English published by the European Commission
Leem · filed 5 Apr 2022 · source
Bringing new therapies to patients is a long, complex and risky process that requires long-term and continuous investments. Patents are critical to that purpose and to the EU’s innovation and industrial ambitions.
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.